Experienced and entrepreneurial executive who creates measurable performance improvement for life-science start-ups, emerging and growth companies, divisions, and teams through research, analytics, and strategy development.

For more than two decades Peter Malamis has strategically guided the growth and development of service firms supporting biopharma clinical research and commercialization.

Along with co-founder Dr. Michael Howley, Peter is focused on the development and launch of a suite of groundbreaking cloud-based software from their company, CRO Analytics, to help improve clinical research management. He also serves as Chief Commercial Officer for ImmunoRestoration, Inc., a start-up in the immuno-oncology space.

Prior to CRO Analytics, Peter was Vice President and General Manager at the MAPI Group where he helped lead the acquisition and integration of Registrat, Inc in a transaction that created the largest global CRO exclusively devoted to post-marketing research.

Previous to MAPI, as President of US Operations for the CRO Premier Research, Peter led that group to highest growth rates and profitability it had ever achieved. Prior to Premier, he held executive positions at SCIREX (US-focused CRO acquired by Premier), Galt Associates (drug safety and software services), MEDTAP International (health economics and outcomes), PAREXEL International (global CRO), State& Federal Associates (market access services).

Peter obtained his B.A. in Political Science at the University of Richmond and his M.B.A. in Marketing from George Washington University. He has served as a Board member and adviser to several early-stage biopharma services companies and is a regular lecturer at Drexel University’s LeBow College of Business MBA in Pharmaceutical Management program as well as at industry conferences.

• 

  Chief Commercial Officer in Realyze

  We combine AI & clinical expertise to accelerate clinical trials, harmonize RWD & drive patient outcomes.